Digital edition of December 2020 print issue
Read the digital edition here. From the December 2020 Issue of McKnight’s Long Term Care News
Read the digital edition here. From the December 2020 Issue of McKnight’s Long Term Care News
Providers are now about halfway through what likely will be the most dangerous stage of the coronavirus crisis and must remain strictly vigilant, the former head of the Food and Drug Administration warned operators.
Long-term care providers must take charge of their own future and become “catalysts of change” for a better life beyond the coronavirus public health crisis, LeadingAge President and CEO Katie Smith Sloan declared during her group’s online annual meeting and expo in November.
Nursing homes in areas that have low COVID-19 positivity rates began receiving rapid testing options from the federal government in November.
A new blood test that can detect the presence of Alzheimer’s brain plaques became the first to hit the commercial market on a wide scale in late October, according to developer C2N Diagnostics.
The Centers for Medicare & Medicaid Services in mid-November announced that Medicare will cover monoclonal antibody therapy for COVID-19 treatments.
Barring a change in direction by the Centers for Medicare & Medicaid Services, nursing home operators will have to slash the amount of therapy services they can offer, starting Jan. 1.
A majority of senior housing and skilled nursing operators were relying on staffing agencies or temporary workers to meet their workforce needs as of mid-November, a provider survey revealed.
Lane Bowen, Executive VP, Chief Strategic Officer, Avalon Health Care
Nursing homes that utilize shared rooms and bathrooms for residents are at a higher risk of experiencing larger and more deadly COVID-19 outbreaks than facilities that house residents mostly in private rooms, a study, whose results appered in the November issue of JAMA Internal Medicine, found.